Quarterly report pursuant to Section 13 or 15(d)

Revenue (Tables)

v3.24.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregated Revenue by Product Line
Disaggregated revenue by product line and segment was as follows:

Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Passenger Segment
Short Distance
$ 32,352  $ 30,388  $ 63,070  $ 59,997 
Jet and Other 6,463  7,607  20,837  23,092 
Total $ 38,815  $ 37,995  $ 83,907  $ 83,089 
Medical Segment
MediMobility Organ Transport $ 36,062  $ 33,447  $ 110,429  $ 94,613 
Total $ 36,062  $ 33,447  $ 110,429  $ 94,613 
Total Revenue
$ 74,877  $ 71,442  $ 194,336  $ 177,702 
Rollforward of Contract Liability Balance The table below presents a roll forward of the contract liability balance:
Nine Months Ended September 30,
2024 2023
Balance, beginning of period $ 6,845  $ 6,709 
Additions 61,177  58,492 
Revenue recognized (61,341) (58,366)
Balance, end of period $ 6,681  $ 6,835